Fact Sheet for Healthcare Providers: LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold) Hangzhou Laihe Biotech Co., Ltd | NLM

Disaster Information Management Research Center | NLM

Fact Sheet for Healthcare Providers: LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold) Hangzhou Laihe Biotech Co., Ltd

06/19/2020 12:00 AM EDT

Source: U.S. Food and Drug Administration (FDA). Published: 6/19/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold). The LYHER Novel Coronavirus (2019-nCoV) IgM/IgG Antibody Combo Test Kit (Colloidal Gold) is authorized for the detection of IgG and IgM antibodies to SARS-CoV-2 in human serum and plasma (dipotassium-EDTA, lithium-heparin, or sodium-citrate). (PDF)